Delivery Order SPE2DB20D1109-SPE2DB24FP12G

Award Date 5/6/24
Potential Completion Date 5/7/24
Potential Value $7.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a total ceiling value of $19,739.04 and an ultimate completion date of May 11, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary...
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., covers the delivery of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical. The firm-fixed-price delivery order, valued at $9,311.44, has a completion date of June 9, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,331.22 for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of March 8, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Trulicity 1.5 mg/0.5 ml pens. The $4,287.10 firm fixed-price delivery order has an ultimate completion date of April 5, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $7,677.94 for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has a completion date of April 8, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $2,322.24 for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,955.80 for the pharmaceutical product Trulicity 4.5 mg/0.5 ml pen. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 22, 2024. The contract is a firm fixed-price delivery order without any set-aside designations, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Trulicity 3 mg/0.5 ml pens. The $9,682.43 fixed-price delivery order has a completion date of March 11, 2024 and was awarded on March 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for the company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Trulicity 1.5 mg/0.5 ml pen 0.5 ml. The contract has a ceiling value of $1,571.65 and a completion date of June 12, 2023. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,814.68 firm-fixed-price delivery order is for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract has an ultimate completion date of April 12, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP12G
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,343.56 and an ultimate completion date of May 7, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract includes critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Additionally, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/27/25, 12:34 PM